Literature DB >> 24523414

Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.

Sudhakar Parthasarathy1, Brian Yoo, Dan McElheny, William Tay, Yoshitaka Ishii.   

Abstract

The interaction of redox-active copper ions with misfolded amyloid β (Aβ) is linked to production of reactive oxygen species (ROS), which has been associated with oxidative stress and neuronal damages in Alzheimer disease. Despite intensive studies, it is still not conclusive how the interaction of Cu(+)/Cu(2+) with Aβ aggregates leads to ROS production even at the in vitro level. In this study, we examined the interaction between Cu(+)/Cu(2+) and Aβ fibrils by solid-state NMR (SSNMR) and other spectroscopic methods. Our photometric studies confirmed the production of ~60 μM hydrogen peroxide (H2O2) from a solution of 20 μM Cu(2+) ions in complex with Aβ(1-40) in fibrils ([Cu(2+)]/[Aβ] = 0.4) within 2 h of incubation after addition of biological reducing agent ascorbate at the physiological concentration (~1 mM). Furthermore, SSNMR (1)H T1 measurements demonstrated that during ROS production the conversion of paramagnetic Cu(2+) into diamagnetic Cu(+) occurs while the reactive Cu(+) ions remain bound to the amyloid fibrils. The results also suggest that O2 is required for rapid recycling of Cu(+) bound to Aβ back to Cu(2+), which allows for continuous production of H2O2. Both (13)C and (15)N SSNMR results show that Cu(+) coordinates to Aβ(1-40) fibrils primarily through the side chain Nδ of both His-13 and His-14, suggesting major rearrangements from the Cu(2+) coordination via Nε in the redox cycle. (13)C SSNMR chemical shift analysis suggests that the overall Aβ conformations are largely unaffected by Cu(+) binding. These results present crucial site-specific evidence of how the full-length Aβ in amyloid fibrils offers catalytic Cu(+) centers.

Entities:  

Keywords:  Alzheimer Disease; Amyloid; Amyloid β; Ascorbic Acid; Copper Binding; Fibril; Hydrogen Peroxide; Reactive Oxygen Species (ROS); Redox Reaction; Solid-state NMR

Mesh:

Substances:

Year:  2014        PMID: 24523414      PMCID: PMC3975043          DOI: 10.1074/jbc.M113.511345

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  86 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

2.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

Review 3.  Copper in the brain and Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Robert Alan Cherny
Journal:  J Biol Inorg Chem       Date:  2009-10-28       Impact factor: 3.358

4.  Pleomorphic copper coordination by Alzheimer's disease amyloid-beta peptide.

Authors:  Simon C Drew; Christopher J Noble; Colin L Masters; Graeme R Hanson; Kevin J Barnham
Journal:  J Am Chem Soc       Date:  2009-01-28       Impact factor: 15.419

5.  Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.

Authors:  Jesse W Karr; Veronika A Szalai
Journal:  Biochemistry       Date:  2008-04-05       Impact factor: 3.162

6.  Quantification of the binding constant of copper(II) to the amyloid-beta peptide.

Authors:  Lanying Q Hatcher; Lian Hong; William D Bush; Tessa Carducci; John D Simon
Journal:  J Phys Chem B       Date:  2008-06-18       Impact factor: 2.991

7.  Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical.

Authors:  Sergey I Dikalov; Michael P Vitek; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2004-02-01       Impact factor: 7.376

Review 8.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

9.  Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

Authors:  Carlos Opazo; Xudong Huang; Robert A Cherny; Robert D Moir; Alex E Roher; Anthony R White; Roberto Cappai; Colin L Masters; Rudolph E Tanzi; Nibaldo C Inestrosa; Ashley I Bush
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

10.  Protein fold determined by paramagnetic magic-angle spinning solid-state NMR spectroscopy.

Authors:  Ishita Sengupta; Philippe S Nadaud; Jonathan J Helmus; Charles D Schwieters; Christopher P Jaroniec
Journal:  Nat Chem       Date:  2012-03-18       Impact factor: 24.427

View more
  12 in total

Review 1.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

2.  On the generation of OH(·) radical species from H2O2 by Cu(I) amyloid beta peptide model complexes: a DFT investigation.

Authors:  Tommaso Prosdocimi; Luca De Gioia; Giuseppe Zampella; Luca Bertini
Journal:  J Biol Inorg Chem       Date:  2015-12-28       Impact factor: 3.358

3.  Structural studies of proteins by paramagnetic solid-state NMR spectroscopy.

Authors:  Christopher P Jaroniec
Journal:  J Magn Reson       Date:  2015-04       Impact factor: 2.229

4.  In vitro effect of H2O 2, some transition metals and hydroxyl radical produced via fenton and fenton-like reactions, on the catalytic activity of AChE and the hydrolysis of ACh.

Authors:  Armando Méndez-Garrido; Maricarmen Hernández-Rodríguez; Rafael Zamorano-Ulloa; José Correa-Basurto; Jessica Elena Mendieta-Wejebe; Daniel Ramírez-Rosales; Martha Cecilia Rosales-Hernández
Journal:  Neurochem Res       Date:  2014-08-06       Impact factor: 3.996

5.  Structural Studies of Amyloid Fibrils by Paramagnetic Solid-State Nuclear Magnetic Resonance Spectroscopy.

Authors:  Theint Theint; Yongjie Xia; Philippe S Nadaud; Dwaipayan Mukhopadhyay; Charles D Schwieters; Krystyna Surewicz; Witold K Surewicz; Christopher P Jaroniec
Journal:  J Am Chem Soc       Date:  2018-10-09       Impact factor: 15.419

Review 6.  Vitamin C, Aging and Alzheimer's Disease.

Authors:  Fiammetta Monacelli; Erica Acquarone; Chiara Giannotti; Roberta Borghi; Alessio Nencioni
Journal:  Nutrients       Date:  2017-06-27       Impact factor: 5.717

7.  Reactivity of Metal-Free and Metal-Associated Amyloid-β with Glycosylated Polyphenols and Their Esterified Derivatives.

Authors:  Kyle J Korshavn; Milim Jang; Yeon Ju Kwak; Akiko Kochi; Silvia Vertuani; Anirban Bhunia; Stefano Manfredini; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

8.  The Influence of Cigarette Smoke Exposure on the Copper Concentration in the Serum Depending on the Use of Menopausal Hormone Therapy.

Authors:  Maria Jasińska-Starczewska; Iwona Szydłowska; Bożena Mroczek; Maria Laszczyńska; Dariusz Chlubek; Ewa Kemicer-Chmielewska; Kornel Chełstowski; Beata Karakiewicz; Sylwester Ciećwież; Andrzej Starczewski
Journal:  Biomed Res Int       Date:  2017-08-14       Impact factor: 3.411

Review 9.  Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals.

Authors:  Soghra Bagheri; Rosanna Squitti; Thomas Haertlé; Mariacristina Siotto; Ali A Saboury
Journal:  Front Aging Neurosci       Date:  2018-01-23       Impact factor: 5.750

10.  Identification of key structural features of the elusive Cu-Aβ complex that generates ROS in Alzheimer's disease.

Authors:  Clémence Cheignon; Megan Jones; Elena Atrián-Blasco; Isabelle Kieffer; Peter Faller; Fabrice Collin; Christelle Hureau
Journal:  Chem Sci       Date:  2017-05-04       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.